東岳(00189.HK)續挫7%失守與配售代理訂立配股價及20天線
最近兩個月股價累積升幅驚人的東岳(00189.HK)連跌第三天,股價承昨天挫6.8%失守10天線勢,今天進一步跌破上周三與配售代理訂立配售價23元及20天線(22.6元),最低見21.5元(較本周二收市價26.15元累挫近18%),現報21.7元,續挫7%,成交續增至8,466萬股。
東岳上周三(1日)與配售代理訂立協議,擬以每股23元(較前一天收市價折讓逾14%)向不少於6名承配人配售1.45億股新股(佔擴大後已發行股本的6.43%),料配售所得淨額33.1億元,將用作提高PVDF及PTFE及其原材料的產能及補充一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.